$AIP

Bayview Legacy, LLC sold $2.1M of AIP (indirect holdings)

Bayview Legacy, LLC sold 100,000 indirectly-held shares of Arteris, Inc. (AIP) at $20.75 ($2.07M total) on 2026-09-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bayview Legacy, LLC
Published Sep 3, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 7:17 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIP
Neutral
medium confidence
Mentioned
$AIP
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

The disclosed sale provides fresh data on insider holdings, useful for short-term trading decisions.

02

Market read

New insider sale information may influence short-term price action.

03

What to watch

Potential upcoming corporate actions not disclosed.

Relevance 5/10Novelty 5/10Timing: post-market today

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$AIPNeutralMedium confidence
Context

Bayview Legacy, LLC sold 100,000 shares of Arteris, Inc. at $20.75 per share via a 10b5-1 plan, reducing its stake to 8.23M shares.

Expected impact

Potential short-term dip of 1-2% as market digests the sale.

Evidence & confidence

Insider is a 10% owner; a $2.1M sale is material for the insider but limited for overall market.

Market effects

Minimal impact on semiconductor design sector.

No significant regional effect.

Limited to investors tracking insider activity.

Counterpoint

Sale could be routine liquidity need, not a negative signal.

Key entities

  • Arteris, Inc.

    Provider of interconnect IP for semiconductor designs.

  • Bayview Legacy, LLC

    10% owner of Arteris, Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to